Target intelligence / Profile preview

Nail keratin (KRT)

Target
KRT
Molecular classification
Intermediate filament, Structural protein
01

Overview

Nail keratin refers to a specialized group of hard, sulfur-rich intermediate filament proteins, primarily trichocyte keratins, that constitute the bulk of the nail plate. These proteins are divided into Type I (acidic, KRT31-KRT40) and Type II (basic-to-neutral, KRT81-KRT86) families, which heteropolymerize to form a dense, resilient matrix. The high cysteine content in these keratins allows for extensive disulfide bond formation, providing the nail with its characteristic hardness and resistance to chemical and mechanical stress.

In clinical pharmacology, nail keratin is a significant target because it acts as both a physical barrier to drug penetration and a reservoir for lipophilic and keratinophilic drugs like terbinafine and itraconazole. Genetic mutations in nail keratins, such as KRT6A or KRT16, lead to pachyonychia congenita, a rare condition characterized by severe nail hypertrophy, which is currently a target for experimental siRNA-based therapies. Additionally, the degradation of nail keratin by fungal keratinases is the primary mechanism of infection in onychomycosis, making the keratin matrix the focal point for antifungal treatment strategies.

Other names
Hard keratinTrichocyte keratinAlpha-keratinOnychokeratinNail plate keratin
02

Mechanism of action

Drugs interact with nail keratin through several mechanisms: antifungal agents like terbinafine and efinaconazole bind to the keratin matrix to create a long-lasting therapeutic reservoir; keratolytics like urea and salicylic acid disrupt hydrogen and disulfide bonds to soften or dissolve the keratin structure for debridement; and experimental RNA interference therapies target the mRNA of mutant keratins to prevent the formation of dysfunctional filaments in genetic disorders.

03

Biological functions

Structural integrityMechanical protectionPermeability barrierProtection of the distal digit
04

Disease associations

OnychomycosisPachyonychia congenitaBrittle nail syndromeNail psoriasisOnychogryphosisTrachyonychia
05

Safety considerations

Low permeability of the dense keratinized nail plate limiting topical drug efficacyNail plate thinning or fragility from excessive keratolysisLocal skin irritation or chemical burns to the nail foldLong treatment durations required due to slow nail growth and keratin turnover
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

KRT6A mutationKRT16 mutationKRT17 mutationCysteine contentKeratin filament aggregation

Beyond the preview

Go deeper on Nail keratin (KRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nail keratin (KRT).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call